These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Effects of tryptophan related compounds on nuclear regulatory control. Possible role in the eosinophilia-myalgia syndrome. Sidransky H; Verney E; Latham P; Schwartz A Adv Exp Med Biol; 1996; 398():343-50. PubMed ID: 8906287 [No Abstract] [Full Text] [Related]
48. Eosinophilia myalgia syndrome. The role of contaminants, the role of serotonergic metabolism set up. Nicolodi M; Sicuteri F Adv Exp Med Biol; 1996; 398():351-7. PubMed ID: 8906288 [No Abstract] [Full Text] [Related]
49. [Eosinophilia-myalgia syndrome in rheumatology]. Nasonov EL; Shtutman VZ; Guseva NG Klin Med (Mosk); 1994; 72(2):17-24. PubMed ID: 8015234 [No Abstract] [Full Text] [Related]
50. [Eosinophilic myositis in a 9 year old boy]. Peña Segura JL; Adrados I; Jiménez Bustos JM; Cabello A; López Pisón J Rev Neurol; 2001 Nov 16-30; 33(10):960-3. PubMed ID: 11785010 [TBL] [Abstract][Full Text] [Related]
57. Intimidation of researchers by special-interest groups. Sternberg EM N Engl J Med; 1997 Oct; 337(18):1316; author reply 1316-7. PubMed ID: 9380084 [No Abstract] [Full Text] [Related]
58. Toxic epidermal necrolysis after paroxetine treatment. Ahmed R; Eagleton C N Z Med J; 2008 May; 121(1274):86-9. PubMed ID: 18535650 [TBL] [Abstract][Full Text] [Related]
59. [Treatment of chronic eosinophilia-myalgia syndrome--effective therapy regimens become evident]. Schnabel A; Arlt AC; Gross WL Z Rheumatol; 1992; 51(4):155-7. PubMed ID: 1414038 [No Abstract] [Full Text] [Related]